X0206 3 2019-11-06 0 0001563577 Galera Therapeutics, Inc. GRTX 0001612133 Sofinnova Venture Partners IX, L.P. C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 0001612134 Sofinnova Management IX, L.L.C. C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 0001202793 POWELL MICHAEL C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 1 0 1 0 0001245624 HEALY JAMES C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 0001590102 Mehra Anand C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 Series B-2 Preferred Stock Common Stock 1797843 D Series C Preferred Stock Common Stock 535869 D The shares reported herein are held of record by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Dr. Michael F. Powell, Dr. James Healy and Dr. Anand Mehra are the managing members of Sofinnova Management IX, L.L.C., the general partner of SVP IX, and as such, may be deemed to share voting and investment power with respect to such shares. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of such person's pecuniary interest therein. Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock on a 0.197763-for-one basis at the holder's election and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. Exhibit 24 - Power of Attorney /s/ Nathalie Auber, attorney-in-fact for Sofinnova Venture Partners IX, L.P. 2019-11-06 /s/ Nathalie Auber, attorney-in-fact for Sofinnova Management IX, L.L.C. 2019-11-06 /s/ Nathalie Auber, attorney-in-fact for Michael F. Powell 2019-11-06 /s/ Nathalie Auber, attorney-in-fact for James Healy 2019-11-06 /s/ Nathalie Auber, attorney-in-fact for Anand Mehra 2019-11-06